Biotechnology Medicare’s Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Stockmarkets Lockheed Martin shares trade lower as Joe Biden seeks to cut F-35 spending By biedexmarkets.com Read more